Neurological disorders are biologically diverse, making diagnosis, patient selection, and treatment response difficult to predict.
R&D Focus
Develops precision medicine to help people with neurological disorders
Innovative Solution
TheraCea Pharma is a biotechnology company that develops precision medicine to help people with neurological disorders. TheraCea Pharma, a University of Arizona spin-off based in Tucson, developed and licensed radiochemistry technology that allows for high-efficiency and rapid fluorine-18 radiolabeling of biomolecules for clinical and research applications.
Investment Funding
Last Funding Stage
Grant
Total Funding Amount
256.K
Last Funding Amount
256.K
Last Funding Date
15-08-2021
Lead Investors
National Science Foundation
People
Founders
Iman Daryaei
Justin Jeffery
About
TheraCea Pharma is a biotechnology company that develops precision medicine to help people with neurological disorders. TheraCea Pharma, a University of Arizona spin-off based in Tucson, developed and licensed radiochemistry technology that allows for high-efficiency and rapid fluorine-18 radiolabeling of biomolecules for clinical and research applications.
Something missing or incorrect on this page? Help us enrich this information
